Zydus Lifesciences (ZYDUSLIFE) — Corporate Action

1 Corporate Action 🔴 High Importance Neutral 📄 PDF

Zydus Lifesciences reported a 69.9% YoY revenue jump to ₹65,279 crores for Q4 FY2025, driving a 100% net profit surge to ₹15,342 crores on strong pharma growth. The board recommended a final dividend of ₹11 per share (1100% payout) pending shareholder approval at the August 12 AGM. The unmodified audit confirms financials are materially accurate, with no new risks disclosed. Trading restrictions lift May 22, 2025.

2 Corporate Action 🔴 High Importance Neutral 📄 PDF

Zydus Lifesciences announced its board approved a final dividend of ₹11 per share (1100% payout) on equity shares of Re. 1, with a record date set for July 25, 2025, and payment scheduled around August 14, 2025, pending shareholder approval at the August 12 AGM.

📊 Stock Analysis — ZYDUSLIFE ✨ Ask AI About This

About Zydus Lifesciences Limited (ZYDUSLIFE)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,01,800.69 Cr P/E: 22.5

View full ZYDUSLIFE stock details →

📡 Get AI alerts when ZYDUSLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZYDUSLIFE — Free

💡 Ask AI about this filing

"How does this corporate action affect Zydus Lifesciences Limited's outlook?" "What did Zydus Lifesciences Limited announce on 20 May 2025?" "Is this positive or negative for ZYDUSLIFE?"

Ask AI Free →

📊 More ZYDUSLIFE filings

See all ZYDUSLIFE filings →

🔥 Also filed on 20 May 2025

TORNTPHARM Torrent Pharmaceuticals Limited Corporate Action SRF SRF Limited Financial Results SIEMENS Siemens Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Corporate Action TORNTPHARM Torrent Pharmaceuticals Limited Financial Results TORNTPHARM Torrent Pharmaceuticals Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZYDUSLIFE files new disclosures

Track ZYDUSLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.